NFKB1 and colitis: The compound ameliorates TNBS-induced colitis via its antioxidant, anti-inflammatory, and immunosuppressive potential, possibly by modulating the Wnt/GSK-3β/β-catenin, p38MAPK, NFκB, and PPARγ signaling pathways.